Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Pancreatic Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01803282
What this trial is testing

Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Chemotherapy in Participants With Advanced Solid Tumors

Who this might be right for
Pancreatic CancerNon-small Cell Lung CancerEsophagogastric Cancer+2 more
Gilead Sciences 236
Testing effectiveness (Phase 2)UnknownNCT00082862
What this trial is testing

Cisplatin, Metronomic Low-Dose Interferon Alfa, Gemcitabine, and Fever-Range Whole-Body Hyperthermia in Treating Patients With Inoperable or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
The University of Texas Health Science Center, Houston 48
Testing effectiveness (Phase 2)Looking for participantsNCT07563738
What this trial is testing

A 2-part Phase 1/2 Open-label Trial on ODM-212

Who this might be right for
MesotheliomaPancreatic CancerNSCLC (Advanced Non-small Cell Lung Cancer)
Orion Corporation, Orion Pharma 229
Early research (Phase 1)UnknownNCT04928625
What this trial is testing

A Trial of SHR-A1904 in Patients With Advanced Pancreatic Cancer

Who this might be right for
Advanced Pancreatic Cancer
Shanghai Hengrui Pharmaceutical Co., Ltd. 75
Testing effectiveness (Phase 2)Looking for participantsNCT06149689
What this trial is testing

MFOLFIRINOX Plus Radiotherapy to Patients With CA19-9-normal Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Adenocarcinoma
Fudan University 30
Not applicableEnded earlyNCT03784417
What this trial is testing

EUS-guided Laser Ablation in Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic AdenocarcinomaPancreas Cancer
Catholic University of the Sacred Heart 5
Testing effectiveness (Phase 2)Looking for participantsNCT06821503
What this trial is testing

Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of LM-108 ± Penpulimab+Chemotherapy in Advanced Solid Tumors - Cohort C

Who this might be right for
Advanced Pancreatic Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 72
Early research (Phase 1)Ended earlyNCT02651727
What this trial is testing

Ph 1 Study of VS-4718, a FAK Inhibitor, in Combination With Nab-paclitaxel and Gemcitabine in Advanced Cancer Subjects

Who this might be right for
Pancreatic Cancer
Verastem, Inc. 13
Testing effectiveness (Phase 2)WithdrawnNCT04134468
What this trial is testing

MRI Effects of Pegvorhyaluronidase Alfa (PEGPH20) in Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Abramson Cancer Center at Penn Medicine
Not applicableStudy completedNCT04478175
What this trial is testing

Prospective Evaluation of a Program for Early Identification of Needs and Multidisciplinary Intervention in Supportive Care in Digestive Oncology

Who this might be right for
Non-colorectal Cancer (Esophagus, Stomach, Liver/Bile Ducts, Pancreas, Neuroendocrine Carcinoma)Colorectal With Associated Risk Factors
Institut Curie 30
Early research (Phase 1)Study completedNCT00385177
What this trial is testing

Phase 1 Dose Escalation Study of SN2310 Injectable Emulsion in Patients With Advanced Solid Tumors

Who this might be right for
Breast NeoplasmsColorectal NeoplasmsPancreatic Neoplasms+2 more
Achieve Life Sciences 61
Testing effectiveness (Phase 2)Active Not RecruitingNCT03485209
What this trial is testing

Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors

Who this might be right for
Colorectal NeoplasmsCarcinoma, Non-Small-Cell LungExocrine Pancreatic Cancer+1 more
Seagen, a wholly owned subsidiary of Pfizer 350
Large-scale testing (Phase 3)Study completedNCT03200821
What this trial is testing

An Open Label Study to Evaluate G17DT Compared to Gemcitabine

Who this might be right for
Pancreatic Cancer
Cancer Advances Inc. 103
Early research (Phase 1)Study completedNCT00066404
What this trial is testing

Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions

Who this might be right for
Cancer
Abramson Cancer Center at Penn Medicine
Early research (Phase 1)Looking for participantsNCT06778863
What this trial is testing

CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

Who this might be right for
Advanced Solid TumorUnresectable Solid TumorMetastatic Solid Tumor+8 more
Clasp Therapeutics, Inc. 90
Early research (Phase 1)Not Yet RecruitingNCT07553793
What this trial is testing

Chimeric Antigen Receptor Macrophages Targeting c-MET for Advanced Stage of Pancreatic Cancer Patients

Who this might be right for
Pancreatic CancerAdvanced Stage Cancer
Peking Union Medical College Hospital 18
Large-scale testing (Phase 3)UnknownNCT02311439
What this trial is testing

Induction Chemotherapy, FOLFIRINOX Followed With Concurrent Capecitabine and Radiation Therapy in Inoperable Locally Advanced Cancer of the Pancreas

Who this might be right for
Cancer of Pancreas
Assiut University 1
Early research (Phase 1)Not Yet RecruitingNCT07738939
What this trial is testing

IKS04 Regimen in Advanced Solid Tumors That Express CA242

Who this might be right for
Colorectal CancerGastro Esophageal Junctional CancerGastric Cancer (GC)+5 more
Iksuda Therapeutics Ltd. 120
Testing effectiveness (Phase 2)Looking for participantsNCT06605430
What this trial is testing

Medical Cannabis in Patients With Advanced Pancreatic and Colorectal Cancer

Who this might be right for
Pancreatic Cancer Non-resectablePancreatic Cancer MetastaticColorectal Cancer Metastatic
HealthPartners Institute 64
Testing effectiveness (Phase 2)Study completedNCT00966706
What this trial is testing

Cisplatin, Capecitabine, Gemcitabine and Epirubicin or Docetaxel for Patients With Stage III or IV Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
IRCCS San Raffaele 105
Next Page